Bortezomib in the treatment of multiple myeloma
Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promisin...
| Cyhoeddwyd yn: | Springer eBooks. |
|---|---|
| Awdur Corfforaethol: | |
| Awduron Eraill: | , , |
| Fformat: | Electronic Resource |
| Iaith: | English |
| Cyhoeddwyd: |
Basel
Springer Basel
c2011.
|
| Pynciau: | |
| Mynediad Ar-lein: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |


